Aastrom Biosciences, Inc. Says FDA Lifts Clinical Hold from Heart Study

Published: Jun 18, 2009

Bookmark and Share

Reuters -- Aastrom Biosciences Inc said U.S. health regulators removed the clinical hold from the company's mid-stage trial of a treatment for congestive heart failure, sending its shares up 39 percent in premarket trade.

Back to news